Protection Against Severe Clinical Outcomes With Adenovirus or Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Patients Hospitalized With Coronavirus Disease 2019.

ABSTRACT:

SUBMITTER: Llibre JM 

PROVIDER: S-EPMC9278196 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature